This ISSM Webinar is on Post SSRI Sexual Dysfunction. The webinar will be opened by Annamaria Giraldi, ISSM President (Denmark). The webinar will be moderated by Alan Shindel (USA) and Marco Gonçalves (Portugal). Topics: Post-SSRI Sexual Dysfunction (PSSD): history and relevance – David...
ABSTRACT Introduction: Post-SSRI sexual dysfunction (PSSD) is an iatrogenic syndrome, the underlying neurobiological mechanisms of which are unclear. Symptom onset follows the cessation of serotonergic antidepressants i.e. Selective Serotonin and Norepinephrine reuptake inhibitors (SSRIs...
Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands (2021) Katherine Chinchilla Alfaro, Florence van Hunsel & Corine Ekhart Abstract Background: Sexual dysfunction is highly prevalent worldwide. A specific form is persistent...
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride, and isotretinoin (2022)
David Healy, Audrey Bahrick, Maarten Bak, Angelo Barbato, Rocco Salvatore Calabrò, Barbara M. Chubak, Fiammetta Cosci, Antonei B. Csoka, Barbara D’Avanzo, Silvia Diviccaro, Silvia Giatti, Irwin Goldstein, Heiko Graf, Wayne J.G. Hellstrom, Michael S. Irwig, Emmanuele A. Jannini, Paddy K.C. Janssen, Mohit Khera, Manoj Therayil Kumar, Joanna Le Noury, Michał Lew-Starowicz, David E.J. Linden, Celine Lüning, Dee Mangin, Roberto Cosimo Melcangi, Omar Walid Muquebil Ali Al Shaban Rodríguez, Jalesh N. Panicker, Arianna Patacchini, Amy M. Pearlman, Caroline F. Pukall, Sanjana Raj, Yacov Reisman, Rachel S. Rubin, Rudy Schreiber, Stuart Shipko, Barbora Vašečková, and Ahad Waraich
Post-finasteride syndrome and post-SSRI sexual dysfunction, are two poorly explored clinical conditions in which men treated for androgenetic alopecia…
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.